Olivares, José M.. - Resultados de la búsqueda - Depósito Digital de Documentos de la UAB

Buscar colecciones:

Ordenar por:	Mostrar resultados:	Formato de visualización:

Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros

Artículos	Encontrados 3 registros

13 p, 734.0 KB

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder : results of a randomized, double-blind clinical trial / Pérez Solà, Víctor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Salavert, Ariana (AB-Biotics S.A) ; Espadaler Mazo, Jordi (AB-Biotics S.A) ; Tuson, Miquel (AB-Biotics S.A) ; Saiz-Ruiz, Jerónimo (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Sáez-Navarro, Cristina (Hospital Universitari Joan XXIII de Tarragona) ; Bobes, Julio (Universidad de Oviedo) ; Baca-García, Enrique (Columbia University) ; Vieta, Eduard (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Olivares, José M.. (Complexo Hospitalario Universitario de Vigo) ; Rodriguez-Jimenez, Roberto (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Villagrán, José M. (Hospital Universitario de Jerez (Jerez de la Frontera)) ; Gascón Barrachina, Josep (Mútua de Terrassa) ; Cañete-Crespillo, Josep (Hospital de Mataró. Consorci Sanitari del Maresme) ; Solé, Montse (Hospital Universitari Joan XXIII de Tarragona) ; Saiz, Pilar A. (Universidad de Oviedo) ; Ibáñez, Ángela (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; de Diego-Adeliño, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Menchón, José M. (Universitat de Barcelona) ; Universitat Autònoma de Barcelona
A 12-week, double-blind, parallel, multi-center randomized controlled trial in 316 adult patients with major depressive disorder (MDD) was conducted to evaluate the effectiveness of pharmacogenetic (PGx) testing for drug therapy guidance. [...]
2017 - DOI (Digital Object Identifier)

10.1186/s12888-017-1412-1
BMC Psychiatry, Vol. 17 (july 2017)

Registro completo -

12 p, 478.7 KB

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice / Ruiz, Miguel A. (Universidad Autónoma de Madrid) ; Álvarez, Enrique (Álvarez Martínez) (Institut d'Investigació Biomèdica Sant Pau) ; Carrasco, Jose L. (Hospital Clínico San Carlos (Madrid)) ; Olivares, José M.. (Complexo Hospitalario Universitario de Vigo) ; Pérez, María (Medical Department, Pfizer, S.L.U.) ; Rejas, Javier (Health Economics and Outcomes Research Department, Pfizer, S.L.U.)
Anxiety disorders are among the most common psychiatric illnesses, with generalized anxiety disorder (GAD) being one of the most common. Sleep disturbances are highly prevalent in GAD patients. While treatment with pregabalin has been found to be associated with significant improvement in GAD-related sleep disturbance across many controlled clinical trials, mediational analysis has suggested that a substantial portion of this effect could be the result of a direct effect of pregabalin. [...]
2015 - DOI (Digital Object Identifier)

10.2147/DDDT.S88238
Drug Design, Development and Therapy, Vol. 9 (august 2015) , p. 4329-4340

Registro completo -

12 p, 586.3 KB

Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors / Álvarez, Enrique (Álvarez Martínez) (Institut d'Investigació Biomèdica Sant Pau) ; Olivares, José M.. (Complexo Hospitalario Universitario de Vigo) ; Carrasco, Jose L. (Hospital Clínico San Carlos (Madrid)) ; López-Gómez, Vanessa (Medical Department, Pfizer, S.L.U., Alcobendas, MD Spain) ; Rejas, Javier (Health Economics and Outcomes Research Department, Pfizer, S.L.U., Alcobendas, MD Spain) ; Universitat Autònoma de Barcelona
This study is done to compare the effect of adjunctive therapy with pregabalin versus usual care (UC) on health-care costs and clinical and patients consequences in generalized anxiety disorder (GAD) subjects with partial response (PR) to a previous selective serotonin reuptake inhibitor (SSRI) course in medical practice in Spain. [...]
2015 - DOI (Digital Object Identifier)

10.1186/s12991-014-0040-0
Annals of General Psychiatry, Vol. 14 (january 2015)

Registro completo -

Vea también: autores con nombres similares
1	Olivares, J. M.

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.